VIDEO
Video abstract.mp4 (125.09 MB)
PRESENTATION
Summary Slide 152.pptx (422.9 kB)
PRESENTATION
Plain Language Summary 152.pptx (428.98 kB)
1/0
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
Version 2 2023-02-15, 00:18
Version 1 2022-12-18, 19:28
media
posted on 2023-02-15, 00:18 authored by Adis Journals on behalf of:, Amy S. Paller, Elaine C Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Mercedes E. Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A. Levit, Randy PrescillaThe above Video Abstract, Key Points and Plain Language Summary represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2022
